secwatch.observer — SEC 8-K summary
======================================

Issuer:     10x Genomics, Inc. (TXG)
CIK:        0001770787
Form:       8-K
Filed at:   2024-01-16T23:59:59+00:00
Accession:  0001770787-24-000007
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CCO James Wilbur to depart 10x Genomics on Feb 1, 2024; gets severance
----------------------------------------------------------------------

- James Wilbur, Chief Commercial Officer, leaving effective Feb 1, 2024; no disagreement with management.
- Severance: six months base salary plus one-time COBRA payment of $14,335.
- No 2023 annual performance bonus for Wilbur.
- Departure not related to company's operations, financial statements, or policies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770787/000177078724000007/0001770787-24-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770787/000177078724000007/txg-20240115.htm
  HTML page:      https://secwatch.observer/filing/0001770787-24-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer